Key points are not available for this paper at this time.
These results lend support to the clinical and cross-cultural validity of the QLQ-BR23 as a supplementary questionnaire for assessing specific quality-of-life issues relevant to patients with breast cancer.
Sprangers et al. (1996) studied this question.